Ionis Pharmaceuticals Inc (STU:ISI)
€ 34.62 0.13 (0.38%) Market Cap: 5.44 Bil Enterprise Value: 4.45 Bil PE Ratio: 0 PB Ratio: 8.55 GF Score: 59/100

Ionis Pharmaceuticals Inc at Guggenheim Healthcare Talks: Immunology and Neurology Day Transcript

Nov 14, 2022 / 07:10PM GMT
Release Date Price: €43.24 (-2.93%)
Operator

Good afternoon, and welcome to Guggenheim's Fourth Immunology and Neurology Conference. My pleasure to host Onaiza Cadoret, EVP of -- and Chief Global Product Strategy and Operations Officer at Ionis; and Eric Swayze, EVP of Research. So welcome. Thank you -- thank you both for joining us today.

Eric E. Swayze
Ionis Pharmaceuticals, Inc. - EVP of Research

Thank you for inviting us. I appreciate it.

Questions & Answers

Operator

So if I could start with you, Eric. Sure. So the dosing array of news items over the last 2 months or so, maybe just for the audience frame us on the overall business -- sort of a business update from the company.

Eric E. Swayze
Ionis Pharmaceuticals, Inc. - EVP of Research

Yes, it'd be great. We have had a pretty event-filled year. I guess, I'd just kind of highlight some of the later-stage programs and maybe a little bit of the technology advancements we've had, starting with eplontersen, which we had positive interim Phase III data out earlier

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot